Laboratory Medicine ›› 2016, Vol. 31 ›› Issue (7): 553-558.DOI: 10.3969/j.issn.1673-8640.2016.07.002
• Orginal Article • Previous Articles Next Articles
CHEN Xiaoqin, REN Jing
Received:
2015-10-12
Online:
2016-07-30
Published:
2016-08-10
CLC Number:
CHEN Xiaoqin, REN Jing. Correlations of serum free fatty acid and insulin resistance with metabolic syndrome[J]. Laboratory Medicine, 2016, 31(7): 553-558.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2016.07.002
组别 | 例数 | 年龄(岁) | 男/女(例) | BMI(kg/m2) | WHR |
---|---|---|---|---|---|
MS组 | 400 | 56.46±13.74 | 180/220 | 23.18±1.53* | 8.56±1.24* |
单纯肥胖组 | 120 | 55.61±7.68 | 52/68 | 23.38±1.31* | 8.91±0.66* |
糖尿病组 | 110 | 59.10±12.60 | 44/66 | 22.45±1.87* | 8.01±0.72* |
高血压组 | 170 | 57.42±10.20 | 79/91 | 23.05±2.03* | 8.29±0.63* |
正常对照组 | 100 | 55.27±11.44 | 45/55 | 21.05±1.87 | 7.89±0.51 |
组别 | HOMA-IR | SBP(kPa) | DBP(kPa) | FFA(mmol/L) | FINS(pmol/L) |
MS组 | 7.38±3.20* | 18.81±1.46* | 11.90±0.93* | 0.59±0.26* | 55.81±20.68* |
单纯肥胖组 | 6.81±1.59* | 16.72±1.52 | 11.47±1.06 | 0.59±0.22* | 57.42±16.25* |
糖尿病组 | 7.81±2.68*# | 17.10±1.49 | 11.76±1.44 | 0.61±0.36*# | 58.89±16.74* |
高血压组 | 6.33±1.68*#△ | 20.11±2.68* #△ | 12.88±2.56* #△ | 0.49±0.17*#△ | 46.00±13.26 |
正常对照组 | 5.62±1.23 | 16.61±1.09 | 11.40±0.81 | 0.37±0.16 | 45.74±15.19 |
组别 | FPG(mmol/L) | TC(mmol/L) | TG(mmol/L) | HDL-C(mmol/L) | LDL-C(mmol/L) |
MS组 | 5.80±1.46* | 4.79±0.95* | 1.70±1.10* | 1.35±0.22* | 3.79±1.07* |
单纯肥胖组 | 5.60±1.46* | 4.89±1.35* | 1.80±1.10* | 1.42±0.22* | 3.82±0.95* |
糖尿病组 | 6.24±1.88* | 4.69±1.10* | 1.56±0.95* | 1.33±0.30* | 3.61±0.73* |
高血压组 | 5.04±1.61 | 4.70±0.82 | 1.42±0.89 | 1.23±0.44* | 3.76±0.84* |
正常对照组 | 4.94±0.88 | 4.65±0.90 | 1.38±0.81 | 1.53±0.34 | 2.85±0.65 |
组别 | 例数 | 年龄(岁) | 男/女(例) | BMI(kg/m2) | WHR |
---|---|---|---|---|---|
MS组 | 400 | 56.46±13.74 | 180/220 | 23.18±1.53* | 8.56±1.24* |
单纯肥胖组 | 120 | 55.61±7.68 | 52/68 | 23.38±1.31* | 8.91±0.66* |
糖尿病组 | 110 | 59.10±12.60 | 44/66 | 22.45±1.87* | 8.01±0.72* |
高血压组 | 170 | 57.42±10.20 | 79/91 | 23.05±2.03* | 8.29±0.63* |
正常对照组 | 100 | 55.27±11.44 | 45/55 | 21.05±1.87 | 7.89±0.51 |
组别 | HOMA-IR | SBP(kPa) | DBP(kPa) | FFA(mmol/L) | FINS(pmol/L) |
MS组 | 7.38±3.20* | 18.81±1.46* | 11.90±0.93* | 0.59±0.26* | 55.81±20.68* |
单纯肥胖组 | 6.81±1.59* | 16.72±1.52 | 11.47±1.06 | 0.59±0.22* | 57.42±16.25* |
糖尿病组 | 7.81±2.68*# | 17.10±1.49 | 11.76±1.44 | 0.61±0.36*# | 58.89±16.74* |
高血压组 | 6.33±1.68*#△ | 20.11±2.68* #△ | 12.88±2.56* #△ | 0.49±0.17*#△ | 46.00±13.26 |
正常对照组 | 5.62±1.23 | 16.61±1.09 | 11.40±0.81 | 0.37±0.16 | 45.74±15.19 |
组别 | FPG(mmol/L) | TC(mmol/L) | TG(mmol/L) | HDL-C(mmol/L) | LDL-C(mmol/L) |
MS组 | 5.80±1.46* | 4.79±0.95* | 1.70±1.10* | 1.35±0.22* | 3.79±1.07* |
单纯肥胖组 | 5.60±1.46* | 4.89±1.35* | 1.80±1.10* | 1.42±0.22* | 3.82±0.95* |
糖尿病组 | 6.24±1.88* | 4.69±1.10* | 1.56±0.95* | 1.33±0.30* | 3.61±0.73* |
高血压组 | 5.04±1.61 | 4.70±0.82 | 1.42±0.89 | 1.23±0.44* | 3.76±0.84* |
正常对照组 | 4.94±0.88 | 4.65±0.90 | 1.38±0.81 | 1.53±0.34 | 2.85±0.65 |
组别 | BMI | WHR | HOMA-IR | SBP | DBP | FINS |
---|---|---|---|---|---|---|
MS组 | ||||||
r值 | 0.581 | 0.480 | 0.321 | 0.215 | 0.267 | 0.223 |
P值 | 0.004 | 0.041 | 0.011 | 0.002 | 0.147 | 0.143 |
单纯肥胖组 | ||||||
r值 | 0.624 | 0.520 | 0.483 | 0.132 | 0.179 | 0.123 |
P值 | 0.007 | 0.010 | 0.026 | 0.431 | 0.320 | 0.496 |
糖尿病组 | ||||||
r值 | 0.534 | 0.634 | 0.658 | 0.142 | 0.139 | 0.519 |
P值 | 0.381 | 0.381 | 0.016 | 0.029 | 0.362 | 0.033 |
高血压组 | ||||||
r值 | 0.532 | 0.485 | 0.358 | 0.776 | 0.682 | 0.361 |
P值 | 0.017 | 0.037 | 0.018 | 0.006 | 0.010 | 0.370 |
正常对照组 | ||||||
r值 | 0.590 | 0.390 | 0.464 | 0.242 | 0.283 | 0.622 |
P值 | 0.041 | 0.030 | 0.011 | 0.028 | 0.475 | 0.008 |
组别 | FPG | TC | TG | HDL-C | LDL-C | |
MS组 | ||||||
r值 | 0.325 | 0.674 | 0.369 | -0.613 | 0.561 | |
P值 | 0.011 | 0.514 | 0.022 | 0.021 | 0.014 | |
单纯肥胖组 | ||||||
r值 | 0.313 | 0.306 | 0.412 | -0.591 | 0.432 | |
P值 | 0.032 | 0.873 | 0.028 | 0.015 | 0.033 | |
糖尿病组 | ||||||
r值 | 0.617 | 0.261 | 0.409 | -0.692 | 0.467 | |
P值 | 0.017 | 0.083 | 0.033 | 0.002 | 0.039 | |
高血压组 | ||||||
r值 | 0.335 | 0.085 | 0.458 | -0.176 | 0.294 | |
P值 | 0.045 | 0.637 | 0.038 | 0.026 | 0.013 | |
正常对照组 | ||||||
r值 | 0.559 | 0.128 | 0.490 | -0.647 | 0.547 | |
P值 | 0.019 | 0.263 | 0.040 | 0.016 | 0.025 |
组别 | BMI | WHR | HOMA-IR | SBP | DBP | FINS |
---|---|---|---|---|---|---|
MS组 | ||||||
r值 | 0.581 | 0.480 | 0.321 | 0.215 | 0.267 | 0.223 |
P值 | 0.004 | 0.041 | 0.011 | 0.002 | 0.147 | 0.143 |
单纯肥胖组 | ||||||
r值 | 0.624 | 0.520 | 0.483 | 0.132 | 0.179 | 0.123 |
P值 | 0.007 | 0.010 | 0.026 | 0.431 | 0.320 | 0.496 |
糖尿病组 | ||||||
r值 | 0.534 | 0.634 | 0.658 | 0.142 | 0.139 | 0.519 |
P值 | 0.381 | 0.381 | 0.016 | 0.029 | 0.362 | 0.033 |
高血压组 | ||||||
r值 | 0.532 | 0.485 | 0.358 | 0.776 | 0.682 | 0.361 |
P值 | 0.017 | 0.037 | 0.018 | 0.006 | 0.010 | 0.370 |
正常对照组 | ||||||
r值 | 0.590 | 0.390 | 0.464 | 0.242 | 0.283 | 0.622 |
P值 | 0.041 | 0.030 | 0.011 | 0.028 | 0.475 | 0.008 |
组别 | FPG | TC | TG | HDL-C | LDL-C | |
MS组 | ||||||
r值 | 0.325 | 0.674 | 0.369 | -0.613 | 0.561 | |
P值 | 0.011 | 0.514 | 0.022 | 0.021 | 0.014 | |
单纯肥胖组 | ||||||
r值 | 0.313 | 0.306 | 0.412 | -0.591 | 0.432 | |
P值 | 0.032 | 0.873 | 0.028 | 0.015 | 0.033 | |
糖尿病组 | ||||||
r值 | 0.617 | 0.261 | 0.409 | -0.692 | 0.467 | |
P值 | 0.017 | 0.083 | 0.033 | 0.002 | 0.039 | |
高血压组 | ||||||
r值 | 0.335 | 0.085 | 0.458 | -0.176 | 0.294 | |
P值 | 0.045 | 0.637 | 0.038 | 0.026 | 0.013 | |
正常对照组 | ||||||
r值 | 0.559 | 0.128 | 0.490 | -0.647 | 0.547 | |
P值 | 0.019 | 0.263 | 0.040 | 0.016 | 0.025 |
1 | BATSIS JA,NIETO-MARTINEZ RE,LOPEZ-JIMENEZ F. Metabolic syndrome:from global epidemiology to individualized medicine[J]. Clin Pharmacol Ther,2007,82(5):509-524. |
2 | ALBERTI KG,ZIMMET P,SHAW J,et al. The metabolic syndrome-a new worldwide definition[J]. Lancet,2005,366(9491):1059-1062. |
3 | FORD ES,GILES WH. A comparison of the prevalence of the metabolic syndrome using two proposed definitions[J]. Diabetes Care,2003,26(3):575-581. |
4 | 李秀钧,钱荣立. 美国糖尿病学会第 64 届学术年会代谢综合征专题简介[J]. 中华糖尿病杂志,2004,12(5):72-73. |
5 | 中华医学会糖尿病学分会代谢综合征研究协作组. 中华医学会糖尿病学分会关于代谢综合征的建议[J]. 中华糖尿病杂志,2004,12(3):5-10. |
6 | 徐成斌. 代谢综合征[J]. 国外医学(内分泌学分册),2005,25(1):3-6. |
7 | GRUNDY SM. Obesity,metabolic syndrome,and cardiovascular disease[J]. J Clin Endocrinol Metab,2004,89(6):2595-2600. |
8 | 诸骏仁,程翔. 代谢综合征靶向治疗的新进展[J]. 临床心血管病杂志,2006,22(1):4-6. |
9 | ROITBERG GE,ARTAMONOVA EA,USHAKOVA TI. Predictive significance of insulin resistance and metabolic syndrome for assessment of the degree of endothelium disfunction and early signs of atherosclerotic lesion[J]. Angiol Sosud Khir,2005,11(2):15-19. |
10 | XI B,HE D,HU Y,et al. Prevalence of metabolic syndrome and its influencing factors among the Chinese adults:the China Health and Nutrition Survey in 2009[J]. Prev Med,2013,57(6):867-871. |
11 | 丁世英,申竹芳,谢明智. PPAR与胰岛素抵抗[J]. 中国药理学通报,2002,18(3):241-245. |
12 | 崔卫东. 空腹血清游离脂肪酸与2型糖尿病的相关性分析[J]. 检验医学,2013,28(7):637-639. |
13 | 李义龙,张延,王萌. 肥胖人群的血清游离脂肪酸水平调查[J]. 中国实验诊断学,2008,12(5):652-654. |
14 | 苏丽,王中心. 血脂异常、2型糖尿病与代谢综合征[J]. 医学综述,2005,11(12):1102-1104. |
15 | 王依屹,张珏,鲁传翠.2型糖尿病患者胰岛素抵抗与血清游离脂肪酸浓度的关系[J].检验医学,2012,27(10):806-808. |
16 | BODEN G.Effects of free fatty acids (FFA) on glucose metabolism:significance for insulin resistance and type 2 diabetes[J]. Exp Clin Endocrinol Diabetes,2003,111(3):121-124. |
17 | SYMONS JD,MCMILLIN SL,RIEHLE C,et al. Contribution of insulin and Akt1 signaling to endothelial nitric oxide synthase in the regulation of endothelial function and blood pressure[J]. Circ Res,2009,104(9):1085-1094. |
18 | AZEKOSHI Y,YASU T,WATANABE S,et al. Free fatty acid causes leukocyte activation and resultant endothelial dysfunction through enhanced angiotensin Ⅱ production in mononuclear and polymorphonuclear cells[J]. Hypertension,2010,56(1):136-142. |
[1] | SUN Wenyuan, WANG Pan, CUI Liyan. Role of brown adipose tissue in insulin resistance and its research progress [J]. Laboratory Medicine, 2023, 38(3): 297-300. |
[2] | CHEN Xuewei, LI Yirong. Candidate biomarkers in metabolic syndrome based on GEO database [J]. Laboratory Medicine, 2023, 38(1): 32-38. |
[3] | CHEN Liang, LI Lin, LI Xia, ZHANG Yan, WU Jiongrui, GAO Yiming. Correlation between metabolic syndrome and moderate-to-severe periodontitis complicated with psoriasis [J]. Laboratory Medicine, 2022, 37(2): 126-129. |
[4] | CHI Wenjing, DING Li, LIU Yixin, YANG Feng, LIU Tao, CONG Jianhua, GAO Zhenhui, ZHAO Hu, ZHANG Yanmei. Correlation analysis of Helicobacter pylori colonization level and metabolic syndrome in physical examination population in Shanghai [J]. Laboratory Medicine, 2022, 37(11): 1034-1038. |
[5] | QU Yuanqing, ZHAO Fan, YE Ailian, LI Lifeng, ZHAO Haitao, LI Huizhen, LIANG Zhuohui, LI Liang. Relationship between plasma omentin-1 level and metabolic clearance rate in type 2 diabetes mellitus patients [J]. Laboratory Medicine, 2022, 37(1): 28-31. |
[6] | ZHOU Zhongwei, JU Huixiang, JIN Hao, CHEN Hongmei, SUN Mingzhong. Relationship between alpha 2-Heremans-Schmid glycoprotein to adiponectin ratio and type 2 diabetes mellitus complicated with metabolic syndrome [J]. Laboratory Medicine, 2020, 35(5): 414-419. |
[7] | ZUO Xuecan, CHU Yanling, LI Zhanping. Relationship between four coagulation factors and C peptide and IR in T2DM patients with microangiopathy [J]. Laboratory Medicine, 2020, 35(4): 327-328. |
[8] | LIU Xiaoni, WANG Ying, LI Taotao, MA Xiaomin, ZHAO Huanlao. Correlation of insulin resistance index and chronic inflammation index in type 2 diabetes mellitus patients with metabolic syndrome [J]. Laboratory Medicine, 2019, 34(9): 826-830. |
[9] | WANG Weicheng, YANG Qiong. Correlation between serum fetuin A level and insulin resistance in patients with hyperthyroidism [J]. Laboratory Medicine, 2019, 34(10): 901-904. |
[10] | GONG Jian, LIU Fang, GAO Peng, XU Jianfeng. Changes of clinical laboratory determination indicators in male androgenic alopecia patients [J]. Laboratory Medicine, 2018, 33(8): 674-678. |
[11] | ZHU Wenkui, XU Qi, CHEN Jin. Correlations of serum calcium and free fatty acid with metabolic syndrome among elders in community [J]. Laboratory Medicine, 2018, 33(5): 407-410. |
[12] | JI Hongbing, JU Huixiang, SUN Mingzhong, CHEN Hongmei, HAN Yuqing, ZHOU Zhongwei. Correlation of the changes of serum alpha2-Heremans-Schmid glycoprotein levels with metabolic syndrome [J]. Laboratory Medicine, 2017, 32(8): 677-680. |
[13] | TANG Jibin, GUAN Jingyi, ZHANG Sheng, LI Xuguang, ZHANG Wen, ZHOU Jiali. Relationship between serum free fatty acid and non-insulin-dependent diabetes mellitus metabolic disorder [J]. Laboratory Medicine, 2017, 32(6): 500-503. |
[14] | GU Keping, WANG Yaping, YU Wei, ZHANG Min, GONG Mengjiao, JIANG Yuhai. Receiver operating characteristic curve for free fatty acid determination in patients with coronary heart disease [J]. Laboratory Medicine, 2017, 32(5): 367-369. |
[15] | XIONG Yongrui, MAO Xiaohong, ZHANG Juanwen, ZHAO Ying, WU Jianping. Clinical significance of serum pancreatic lipase in nonalcoholic fatty liver disease [J]. Laboratory Medicine, 2016, 31(3): 180-184. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||